New Prospects for the Application of Om-85: A Literature Review
Open Access
- 1 October 2026
- journal article
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 23 (4) , 466-475
Abstract
The bacterial lysate OM-85 is a well-studied immunomodulator with a favorable safety profile. Its efficacy in the prevention and combination therapy of recurrent respiratory infections in children has been confirmed by numerous clinical trials, which have demonstrated a reduction in infection frequency, antibiotic use, and disease duration. Mechanistically, OM-85 induces interferon synthesis, enhances secretory IgA production, and modulates the T-helper (Th) balance by promoting a Th1-skewed response and activating regulatory T cells. These immunomodulatory properties open up prospects for its use as part of combination therapy in T2-mediated conditions, including bronchial asthma, allergic rhinitis, and atopic dermatitis. Promising directions for further research include evaluating the efficacy of extended OM-85 courses lasting up to 6–9 months, as well as investigating its role in the primary prevention of allergic diseases. Thus, the potential of OM-85 is not limited to the prevention of respiratory infections and may extend to the development of novel approaches for managing a broad range of immune-mediated disorders.Keywords
This publication has 48 references indexed in Scilit:
- The impact of bacterial lysate (OM-85) on clinical and immunological parameters in children with allergic rhinitisEuropean Archives of Oto-Rhino-Laryngology, 2025
- The impact of the COVID-19 pandemic on influenza, respiratory syncytial virus, and other seasonal respiratory virus circulation in Canada: A population-based studyThe Lancet Regional Health - Americas, 2021
- The dual function of ILC2: From host protection to pathogenic players in type 2 asthmaMolecular Aspects of Medicine, 2021
- Stereotypic Immune System Development in Newborn ChildrenCell, 2018
- Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysisInternational Immunopharmacology, 2018
- An exposome perspective: Early-life events and immune development in a changing worldJournal of Allergy and Clinical Immunology, 2017
- OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic reviewWorld Journal of Pediatrics, 2010
- Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative reviewEuropean Journal of Pediatrics, 2006
- Immunostimulants for preventing respiratory tract infection in childrenCochrane Database of Systematic Reviews, 2006
- Use of Broncho-Vaxom® in private practice: Phase IV trial in 587 childrenClinical Therapeutics, 1996